By Allu Vagdevi - Career researcher and writer Career after PhD in life sciences means choosing between five genuinely different tracks — academia, senior industry R&D, government scientist posts, regulatory affairs or medical writing, and independent consulting — not just "postdoc, then hope for a professorship." The decision here is different from a fresh graduate's: you have already invested five-plus years and cleared CSIR-UGC NET or GATE and a doctorate, so the real question is which track turns that specific depth into income, and which one leaves you stuck on ad-hoc pay while you wait for a permanent post that may not come.
The short version
- A PhD in life sciences opens five real tracks: independent consulting/science-writing, regulatory affairs and medical writing, senior industry R&D, CSIR/DBT/ICMR scientist posts, and academia — each with a different pay ceiling and risk.
- The strongest long-term ceiling usually sits in independent consulting or a science-writing practice you own, followed by regulatory affairs/medical writing and senior industry R&D — all three scale with reputation and specialisation in ways a fixed government pay scale cannot.
- Academia after a PhD is not one competition finishing; it is a postdoc stage followed by a second, separate, scarce faculty-hiring competition most families never hear about until they are already years in.
- Regulatory affairs and medical/scientific writing are the most underused lane for a life-sciences PhD, and they reward exactly the skill a doctorate builds: reading data critically and writing about it precisely.
- Turning your specific research depth into a public, findable body of work — a paper, a sample dossier, a writing portfolio — is what actually moves any of these five tracks toward real income and earlier financial freedom, not the PhD label by itself.
If you are still weighing whether life sciences was the right undergraduate or postgraduate choice at all, or comparing the wider BSc/MSc-level career map before deciding on a PhD, this article assumes you have already finished, or are close to finishing, the doctorate. For the broader four-track map most life-science graduates start from, read biological sciences career options in India, or browse the full Career Options collection for other paths.
If you are close to a real decision here — accepting a postdoc offer abroad, applying to an industry R&D role, or testing regulatory affairs for the first time — a session inside career guidance can weigh this specific move against your own runway and family situation, not a generic list.
The short answer for PhD holders
A life-sciences PhD is not a one-way ticket into a postdoc and, eventually, a lecture hall. It is a credential in original research, rigorous data reading, and technical depth — a credential that genuinely feeds five different career tracks, each with its own pay structure, timeline, and risk.
The confusion for most PhD holders is not a shortage of options. It is that the default advice — "do a postdoc, then keep applying for faculty posts" — treats academia as the only serious destination, when three of the five tracks below can pay as well or better, faster, and one of them, regulatory affairs and medical writing, barely gets mentioned at all in most departments.
Why a finished PhD changes the decision
Why this is a different question than "what can a life sciences graduate do"
- You have already spent five-plus years and cleared CSIR-UGC NET, GATE, or a DBT/ICMR-JRF exam — a fresh graduate is choosing whether to start that; you are choosing what to do with it now that it is done.
- You can enter industry R&D at scientist or senior scientist level, not the entry research-associate rung most BSc/MSc graduates start at.
- A postdoc stage, ad-hoc teaching pay, and a second, separate faculty or scientist recruitment are a real near-term reality specific to people who have already finished a PhD, not a hypothetical future problem.
- Regulatory affairs and medical/scientific writing become genuinely accessible lateral moves only once you have the depth and the writing discipline a PhD builds, not something a fresh graduate can step into as easily.
The 5 real tracks, ranked by growth — not by prestige
The order below follows real scalability and growth headroom as you gain reputation and proof, not which title sounds most respectable at a family gathering. The tracks with real ownership or an uncapped pay structure come first; the tracks locked to a fixed government or institute scale come last, regardless of how prestigious they sound.
Freelance medical writing, scientific editing, regulatory dossier consulting, or a public science-communication platform built on your specific specialisation. You set the scope, the client list, and the pricing.
A PhD gets you into a regulatory or medical-writing team well above the fresher entry rung, writing clinical study reports, dossiers, and manuscripts that pharma, biotech, and CROs pay a premium for precisely because most PhDs never consider this lane.
A PhD enters an R&D bench at scientist or senior scientist level, not the entry research-associate rung a fresh BSc/MSc starts at. Biocon, Dr Reddy's, Bharat Biotech, Serum Institute, Syngene, and multinational R&D centres in India all hire at this level.
A formal Scientist-grade recruitment separate from your PhD fellowship years, on a fixed government pay ladder. Genuinely respected, stable research work, but seats are scarce relative to the number of qualified PhD-plus-postdoc applicants every cycle.
A funded PhD gets you the doctorate. It does not get you a lab of your own. Most researchers spend years on postdoctoral fellowships, often abroad, before even being eligible for a permanent Assistant Professor search at an IISER, IIT, central university, or research institute.
Honest take
Academia sits last on this list, not first, and that is deliberate. It is real, valuable work for people who genuinely love research and teaching. But its pay is fixed by a UGC or institute scale, its permanent-post market has not kept pace with the number of qualified PhD-plus-postdoc researchers, and the tracks above it can reach a comparable or higher ceiling faster for someone willing to build a specialisation and a public track record rather than wait for a selection committee.
Track 1: independent consulting and a science-writing or content practice
This is the track most PhD holders underuse, because doctoral training rewards writing for three peer reviewers, not for a paying client or a public audience. It is also the one with the most genuine room to scale. Pharma companies, biotech start-ups, CROs, and science-media platforms all pay for a named specialist who can turn deep technical knowledge into a client-ready regulatory summary, a data-backed explainer, or a scientific-content series, on a retainer or project basis.
A related and often underrated version: building your own platform — a science newsletter, an explainer channel, or a niche consulting practice in your exact sub-field (immunology, plant genomics, microbiome research, oncology drug targets, and so on) — that you own outright instead of publishing only inside journals few outside your field will ever read.
Why this scales when the others don't: you set your own pricing instead of sitting on a government or UGC pay scale, demand repeats with every new drug approval, clinical trial, or research paper rather than depending on one employer's budget, and once you have a track record you can bring on junior writers or researchers instead of doing every hour yourself. A public platform built the same way carries the identical advantage — reach and reputation that a journal paywall or a single company's payroll cannot cap.
The entry route is rarely a cold pitch straight after the viva. Most PhD holders build this by publishing one or two public-facing pieces — a data-backed explainer, a guest article for a science-media outlet, a sample regulatory or medical-writing document — that translate the dissertation into something a client or an editor outside academia can actually use and find.
If you are seriously weighing the leap into independent consulting rather than staying inside an institution, read how to become an independent consultant in India for the readiness test before you leave a stable stipend or salary for retainer clients.
Track 2: regulatory affairs and medical/scientific writing
This is the least discussed real career on this list, and arguably the best structural fit for a PhD's actual skills. Regulatory affairs teams write and review the dossiers that get a drug, vaccine, or medical device approved; medical and scientific writers produce clinical study reports, manuscripts, regulatory submissions, and patient-facing materials for pharma companies, contract research organisations, and dedicated medical-communications agencies.
Both functions specifically want people who can read primary data critically and explain it precisely, to a strict format and a hard deadline — exactly what finishing a doctorate trains you to do, whether or not your dissertation had anything to do with drug regulation. A PhD commonly enters above the fresher writer or associate rung most BSc/MSc graduates start on, and experienced writers move into lead-writer, regulatory-strategy, or freelance consulting roles faster than a pure bench researcher typically moves into R&D management.
Honest take
This track has a real structural advantage most PhD holders never test: demand is steady (every drug and device approval needs a dossier), the work is less physically demanding than a bench role, it is more remote-friendly than lab-based industry work, and freelance rates scale genuinely well once you are senior and specialised. Most people who avoid it do so because it "sounds less like real science," not because the pay or growth is actually worse.
Entry routes include a company's in-house regulatory affairs or medical writing team, a CRO, a medical-communications agency, or a certificate course in regulatory affairs or medical writing to build the format-specific skills (ICH-GCP documentation standards, common technical document formats) that a pure PhD does not teach directly.
Track 3: senior industry R&D roles in pharma and biotech
Research and development benches at Biocon, Dr Reddy's Laboratories, Bharat Biotech, the Serum Institute of India, Syngene International, Cipla, Sun Pharma, Piramal Pharma, and the growing Indian R&D centres of multinational pharma and biotech companies are usually where a fresh BSc/MSc graduate enters this world as a research associate. A PhD holder is a different candidate: the doctorate, combined with published work, commonly qualifies you to enter directly at scientist or senior scientist level, skipping the entry rung most fresh graduates start on.
That matters for pay and influence both. A scientist-level hire is expected to lead a specific project workstream, mentor junior researchers, and often interact directly with regulatory or clinical teams — work that compounds into a genuine management ladder toward principal scientist or R&D lead over 10-15 years, a clearer progression than most academic tracks offer in the same period.
Honest take
India's biotech and pharma R&D sector has been genuinely expanding, with more companies building dedicated research units rather than only manufacturing generics, and multinational firms opening larger India-based R&D and biologics centres. This is a real structural tailwind for the industry track specifically, not a claim that applies equally to every track on this list.
For the wider BSc/MSc-level industry landscape this overlaps with, including entry-level R&D, QC, and clinical research roles that do not require a doctorate, read BSc biotechnology career options in India.
Track 4: CSIR/DBT/ICMR/ICAR scientist posts, post-PhD
National research bodies — the Council of Scientific and Industrial Research, the Department of Biotechnology, the Indian Council of Medical Research, and the Indian Council of Agricultural Research — run their own Scientist-grade recruitment separate from the JRF/SRF fellowship years you spend during the PhD itself. A candidate typically applies for a formal Scientist B or C post through a dedicated written exam and interview after finishing the doctorate, then climbs a fixed government pay ladder toward Senior Scientist, Principal Scientist, and eventually a directorial role over 10-15+ years.
Honest take
Seats across all of these bodies are genuinely scarce relative to the size of the applicant pool every recruitment cycle. This is real, stable, respected research work, not a fallback option, but it should be pursued for the actual work and stability it offers, not as an assumed backup if academia or industry does not work out.
Track 5: academia — postdoc to a permanent faculty post
If you genuinely love the research and teaching itself, academia is real, valuable work, and it is the path you have already started. It is also the track with the longest and most uncertain runway from where you stand right now, because finishing the PhD does not finish the competition — it adds a postdoctoral stage, then restarts the competition in a different, less discussed form.
Most researchers spend two to six years doing postdoctoral work, often at a foreign university or lab, before even being eligible for a permanent faculty search at an IISER, an IIT, a central university, or a national research institute. A real bridge exists for researchers building an international postdoc career and wanting a route back into an Indian faculty or scientist post: fellowships like the DBT-run Ramalingaswami Re-entry Fellowship are specifically designed to help a returning researcher re-establish a lab at an Indian institution with startup research funding. It is a genuinely useful bridge, not a guarantee of a permanent seat once the fellowship period ends.
How assistant professor and scientist hiring actually works, stage by stage
Most PhD holders know they need to publish and finish a postdoc. Far fewer have mapped the actual hiring process for a permanent post, which typically runs through four separate stages, each of which can eliminate a genuinely qualified candidate.
Universities and institutes score applications on a points system covering your degrees, publications, postdoctoral output, and grants before shortlisting anyone for the next stage.
A department or institute selection committee narrows the screened pool further, often favouring candidates whose sub-field matches an open post's specific requirement and whose postdoc produced strong, independent-looking publications.
A panel, often including external subject experts, questions you on your research and your plans for an independent lab — a chalk-talk or seminar presenting your proposed research programme is a standard part of this stage, testing clear explanation as much as research depth.
Even after an offer, a new faculty member typically negotiates startup research funding and physical lab space before the role becomes a functioning position, a stage that varies widely by institute and can delay actually starting real research for months.
Even after all four stages, a confirmed offer depends on an actual sanctioned vacancy existing in your specific sub-field, at an institute you can realistically relocate to. A brilliant publication record in a niche you specialised in can sit unmatched to any open post for a long stretch, simply because of subject-fit and geography.
The competition that restarts after your viva
Two tracks on this list share a pattern the "just finish the PhD and do a postdoc" framing hides completely: clearing the well-known filter does not end the competition. It restarts it, in a different form, right when you expect to finally be done.
You qualified CSIR-UGC NET, GATE in a life-sciences discipline, or a DBT/ICMR-JRF entrance exam, found a funded seat, and spent roughly five to six years, sometimes longer, finishing original research under a supervisor. That is genuinely hard, and it is now behind you.
Most researchers spend two to six years on postdoctoral fellowships, commonly abroad, before they are even eligible to apply for a permanent faculty search. A confirmed Assistant Professor post then runs through paper screening against a points-based academic record, shortlisting, a selection-committee interview, and often a seminar or chalk-talk in front of the department. Ad-hoc and guest-faculty teaching, paid per lecture with no guaranteed income during vacation months, is where many qualified PhD-plus-postdoc researchers spend several years before, if ever, reaching a permanent seat.
CSIR-UGC NET, GATE, or a DBT/ICMR-JRF exam is a real, single-digit-percentage-selection filter on its own, and a funded PhD seat with a good supervisor is scarcer still.
Entry into a permanent CSIR, DBT, ICMR, or ICAR Scientist B/C post is not automatic after finishing a PhD. It runs through its own written exam and interview cycle, held periodically, with a limited number of sanctioned posts nationally relative to the number of qualified applicants finishing PhDs and postdocs every year.
This is a genuinely different caution from ordinary "research careers are competitive," which shows up in industry R&D hiring too. There, one strong published portfolio can open the door, and your growth from there depends mostly on the work you keep producing. In academia and government-scientist recruitment, a second, separate filter — years of postdoctoral work plus a scarce permanent-post market on one side, a dedicated exam-and-interview cycle on the other — sits between "I finished the hard part" and "I actually reached the role and pay I pictured."
What AI is doing to life-science research
Every track on this list runs on reading data, running experiments, and writing about the results — exactly the layer AI tools are changing fastest. The honest picture has a real risk side and a real opportunity side, and for a PhD holder specifically, they are not the same task.
- First-pass literature reviews and summarising hundreds of abstracts is already shifting into AI-assisted workflows at many labs and research teams.
- Routine data processing, plate-reading logs, and basic descriptive analysis of standard datasets is now faster with AI tools than doing it by hand, reducing demand for pure data-entry-adjacent research support.
- Template-based regulatory-document and standard operating procedure drafting is easier to automate than original clinical or regulatory judgment, so purely formulaic writing carries more exposure than strategic writing.
- AI-assisted literature review and drug-target screening: feeding a large body of prior research or a compound library into an AI tool for a fast first-pass synthesis, then spending your real time on the original hypothesis and judgment call only your specialisation can make.
- Faster manuscript, dossier, and grant drafting: turning raw data and lab notes into a client-ready or committee-ready document far faster than before, provided you personally verify every claim before it goes out under your name.
- A named specialist with real depth can now run a serious science newsletter or consulting practice with AI-assisted editing and research support that used to need a small editorial team — a direct multiplier on Track 1's ownership advantage.
Right now: use AI tools to speed up literature synthesis and first drafts, but verify every citation, statistic, and experimental claim manually before it appears in a published paper, dossier, or client report — a factual error under your name is a credibility problem a PhD is specifically supposed to prevent.
As adoption matures: the differentiated value shifts further toward original wet-lab work, primary data you generate yourself, and client-specific or regulator-specific judgment that a general-purpose AI tool cannot originate. That is a strong argument for keeping one active research or writing project running at all times, rather than treating the dissertation as a finished, closed chapter.
How to choose your track: The 4-Checkpoint Protocol
Before you commit further years — a postdoc, a CSIR scientist attempt, an unpaid content experiment, or a leap into freelance regulatory writing — run the track you are leaning toward through The 4-Checkpoint Protocol. It will not hand you a single correct answer. It will surface the honest trade-offs a rank list, a placement office, or a family opinion never will.
Academia and government research reward people who like long solitary bench or desk work, mentoring, grant writing, and slow-building results. Industry R&D, regulatory affairs, and consulting reward people energised by deadlines, cross-functional teams, and client or regulator expectations. A strong bench researcher forced into constant stakeholder meetings will underperform regardless of the pay slip.
You have already spent years of income and, often, family patience on the doctorate. A postdoc, a CSIR scientist attempt, or a leap into freelance medical writing all assume more months to years of thin or uncertain income before it stabilises. Be honest about how much more runway you and your family genuinely have.
Pharma R&D teams, regulatory affairs departments, and medical-writing agencies hire off a portfolio of published papers, a specific technical specialisation, or a writing sample, not off the PhD title alone. Name the one publication, dataset, or writing sample you would show before someone pays you for this track.
A role built mostly around routine literature summarising or template documentation is more exposed than one built around original wet-lab troubleshooting, experimental design, or regulatory judgment a client is paying for specifically. Check the actual task mix of the role you are aiming at, not the job title.
Skills that matter after a PhD
A PhD gives you a real starting depth — original research, technical rigour, and subject command. What turns that depth into a genuine high-income skill portfolio, and eventually earlier financial freedom, is a deliberate stack built on top of the dissertation, not the degree title alone.
- Translation writing — turning a dissertation chapter or a journal finding into a regulatory summary, a client memo, or a public explainer a non-specialist can actually use. This is the single biggest gap between a PhD holder who gets hired quickly and one who does not.
- Regulatory and documentation literacy — comfort with GLP, ICH-GCP formats, and audit-ready reporting. This is what actually gets someone promoted inside an industry regulatory affairs or quality function, more consistently than raw bench talent alone.
- Statistics and data literacy — comfort with the specific datasets your sub-field generates, even for a primarily wet-lab researcher. This is the multiplier skill that separates a median industry hire from a strong one, and it is exactly what AI-assisted research now rewards.
- Grant and scientific writing, in plain, persuasive language — funding, in academia and in government labs alike, is won by researchers who can explain why their specific question matters to a funding committee, not only by researchers with the best raw ideas.
- Negotiation and stakeholder management — the human layer behind industry R&D leadership, consulting, and client work that AI does not touch. Client and institutional trust stay entirely human.
- Practical AI fluency — using AI tools to speed up literature review and drafting while personally verifying every output, per the AI section above.
Realistic pay across all 5 tracks
No single "PhD in life sciences salary" exists, because these five tracks sit on entirely different pay structures. Here is the honest range by track, with the caveats noted where a figure is genuinely uncertain or institution-specific.
| Track | Realistic pay | Notes |
|---|---|---|
| Independent consulting & science-writing practice | Highly variable, upside-driven | Income scales with retainer clients, per-project regulatory or medical-writing fees, and a content or newsletter audience rather than a fixed band. A well-known specialist consultant can out-earn a senior scientist; someone with no visible track record earns very little at first. |
| Regulatory affairs & medical/scientific writing (freelance senior level) | Roughly Rs 8-18 LPA-equivalent for an employed senior role; freelance per-document rates scale further with reputation | A genuinely under-discussed lane. A PhD with strong writing skills commonly enters above the fresher writer rung and moves into lead-writer or regulatory-strategy roles faster than a pure bench researcher moves into R&D management. |
| Senior industry R&D scientist, pharma/biotech | Roughly Rs 8-15 LPA entry at scientist/senior scientist level, Rs 18-30+ LPA at principal scientist or R&D lead with 10-15 years | A PhD typically enters above the entry research-associate rung a fresh BSc/MSc starts on. Biocon, Dr Reddy's, Bharat Biotech, Serum Institute, Syngene, Piramal, and multinational R&D centres in India all recruit PhD-level scientists directly into this band. |
| CSIR/DBT/ICMR/ICAR Scientist B/C (post-PhD, formal recruitment) | Roughly Rs 6-9 LPA entry, rising to Rs 15-22 LPA at Senior/Principal Scientist over 10-15+ years | Reached through a formal Scientist-grade exam and interview, separate from the JRF/SRF fellowship years spent during the PhD itself. Pay follows a fixed government pay-matrix ladder with DA, HRA, and increments. |
| Academia: permanent Assistant Professor (after PhD and postdoc) | UGC/institute scale from Level 10 basic roughly Rs 9-14 LPA once confirmed; ad-hoc and guest-faculty pay is considerably lower and often per lecture | Many PhD-plus-postdoc researchers spend years on ad-hoc, guest-faculty, or short-term contractual teaching work, with no guaranteed income during vacation months, before a permanent post opens, if one opens at all in their specific sub-field and preferred city. |
Figures are directional and India-wide, drawn from published UGC and government pay scales, industry salary-tracking sources, and general knowledge of medical-writing and regulatory-affairs pay bands at the time of writing. Verify current figures on the relevant official source or live job postings before making a financial decision based on any single number here.
Testing a track before you commit further years
A qualification checklist tells you what is formally required. It cannot tell you whether you will actually get hired, or enjoy the work, before you spend more years finding out the hard way. Test that first, using The 3 Gates.
Do not accept a postdoc offer, start a CSIR scientist attempt, or leap into freelance regulatory writing before passing all three gates below.
One peer-reviewed paper beyond your dissertation, one clinical study report or regulatory dossier section written to a real CRO or company format, or one science-communication piece that translates your specialisation for a non-specialist reader.
Explain your specialisation and its real-world stakes to someone outside your sub-field in under two minutes. If a stranger cannot see why it matters, a hiring committee, a regulatory team, or a science editor will struggle to trust your writing either.
Get one honest reaction from someone who did not have to give it — an editor who accepted your science piece, a regulatory affairs lead who reviewed your sample dossier, or a company that paid you for a short piece of consulting or writing work.
Practical proof formats that work across almost every track above: a published paper beyond your dissertation, a sample clinical study report or regulatory document written to a real company or CRO format, a conference presentation outside your own institute, a short-term consultancy or internship with a pharma company, a CRO, or a medical-communications agency, and a public archive of your writing, even a simple science newsletter, tracking your specialisation consistently.
Mistakes to avoid
Hiring managers at serious pharma and biotech companies look for publications, technical specialisation, and, for regulatory or writing roles, an actual writing sample beyond the dissertation. A finished thesis with nothing published or demonstrated outside academia reads as potential, not proof.
A postdoc genuinely strengthens a publication record, but an open-ended series of postdocs with no plan for the faculty market, the industry market, or a specific re-entry fellowship is one of the most common ways years quietly pass without a stronger outcome.
Ad-hoc and guest-faculty work has kept many qualified PhDs afloat for years at a stretch across Indian universities and institutes, not months. Plan your finances and your next application cycle around that reality, not around a best-case timeline.
This is the single most underused lane on this list for a life-sciences PhD. Regulatory teams and medical-writing agencies specifically want people who can read primary data and explain it precisely, which is exactly what a doctorate trains you to do.
The waiting period between finishing a PhD or postdoc and landing a permanent role is exactly when a public science-communication piece, a preprint, or a sample regulatory document compounds fastest. Silence during this stretch is the most expensive mistake on this list.
What to do next
Do not default to "do another postdoc" simply because it is the track everyone assumes a life-sciences PhD leads to. The label that sounds most respectable does not have the strongest growth curve, and the second, separate competition inside academia and government-scientist recruitment rarely gets explained honestly before someone spends more years assuming it away.
Pick the track using The 4-Checkpoint Protocol above — your energy, your real remaining runway, current market demand for your specialisation, and AI exposure — not just which title sounds most impressive today.
Then pass The 3 Gates on one small, real test before you commit a postdoc, a scientist-exam attempt, or a freelance regulatory-writing project to it.
Reaching earlier financial freedom from any of these five tracks comes down to a genuine high-income skill portfolio — translation writing, regulatory literacy, statistics, and negotiation — built deliberately and proven publicly, not the PhD title by itself. Move toward that with career guidance if you want a second opinion on your specific situation, or start with the free career and skill assessments if you are still unsure which track genuinely fits you.
Still comparing this against the wider entry map most life-science graduates start from? Read biological sciences career options in India for the BSc/MSc-level version of this decision, or BSc biotechnology career options in India for entry-level industry roles that do not require a doctorate.